Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis

Respiratory Medicine

Volumn 102, Issue 3, 2008, Pages 464-469

  Lee, Keu Sung ^a   Choi, Young Hwa ^a   Kim, Young Sun ^a   Baik, Seung Hee ^a   Oh, Yoon Jung ^a   Sheen, Seung Soo ^a   Park, Joo Hun ^a   Hwang, Sung Chul ^a   Park, Kwang Joo ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Acute respiratory distress syndrome; Apoptosis; Bronchoalveolar lavage; Chemokine; Epithelial cell; Neutrophil

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 18; FAS ANTIGEN; FAS LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH RELATED ONCOGENE ALPHA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG INJURY; LUNG LAVAGE; MALE; MEDIATOR; MULTIPLE ORGAN FAILURE; NEUTROPHIL COUNT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; EPITHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 38749154283     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.10.001     Document Type: Article

References (38)

1. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 342 (2000) 1334-1349
2. Bhatia M., and Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202 (2004) 145-156
3. Martin T.R., Nakamura M., and Matute-Bello G. The role of apoptosis in acute lung injury. Crit Care Med 31 (2003) S184-S188
4. Matute-Bello G., and Martin T.R. Science review: apoptosis in acute lung injury. Crit Care 7 (2003) 355-358
5. Aggarwal A., Baker C.S., Evans T.W., and Haslam P.L. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 15 (2000) 895-901
6. Lesur O., Kokis A., Hermans C., Fulop T., Bernard A., and Lane D. Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival. Crit Care Med 28 (2000) 3814-3822
7. Kettritz R., Gaido M.L., Haller H., Luft F.C., Jennette C.J., and Falk R.J. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int 53 (1998) 84-91
8. Glynn P.C., Henney E., and Hall I.P. The selective CXCR2 antagonist SB272844 blocks interleukin-8 and growth-related oncogene-alpha-mediated inhibition of spontaneous neutrophil apoptosis. Pulm Pharmacol Ther 15 (2002) 103-110
9. Hashimoto S., Kobayashi A., Kooguchi K., Kitamura Y., Onodera H., and Nakajima H. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 161 (2000) 237-243
10. Matute-Bello G., Liles W.C., Frevert C.W., Nakamura M., Ballman K., Vathanaprida C., et al. Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol 281 (2001) L328-L335
11. Matute-Bello G., Liles W.C., Steinberg K.P., Kiener P.A., Mongovin S., Chi E.Y., et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 163 (1999) 2217-2225
12. Albertine K.H., Soulier M.F., Wang Z., Ishizaka A., Hashimoto S., Zimmerman G.A., et al. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161 (2002) 1783-1796
13. Secchiero P., Gonelli A., Carnevale E., Milani D., Pandolfi A., Zella D., et al. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107 (2003) 2250-2256
14. Secchiero P., Corallini F., di Iasio M.G., Gonelli A., Barbarotto E., and Zauli G. TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release. Blood 105 (2005) 3413-3419
15. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
16. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
17. Vincent J.L., de Mendonca A., Cantraine F., Moreno R., Takala J., Suter P.M., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 26 (1998) 1793-1800
18. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Sprung C.L., and Sibbald W.J. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23 (1995) 1638-1652
19. Murray J.F., Matthay M.A., Luce J.M., and Flick M.R. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 138 (1988) 720-723
20. Kramer G., Erdal H., Mertens H.J., Nap M., Mauermann J., Steiner G., et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res 64 (2004) 1751-1756
21. Bardales R.H., Xie S.S., Schaefer R.F., and Hsu S.M. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 149 (1996) 845-852
22. Wiedermann F.J., Mayr A.J., Hobisch-Hagen P., Fuchs D., and Schobersberger W. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res 23 (2003) 729-736
23. Villard J., Dayer-Pastore F., Hamacher J., Aubert J.D., Schlegel-Haueter S., and Nicod L.P. GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am J Respir Crit Care Med 152 (1995) 1549-1554
24. Wiedermann F.J., Mayr A.J., Kaneider N.C., Fuchs D., Mutz N.J., and Schobersberger W. Alveolar granulocyte colony-stimulating factor and alpha-chemokines in relation to serum levels, pulmonary neutrophilia, and severity of lung injury in ARDS. Chest 125 (2004) 212-219
25. Iwase M., Kondo G., Watanabe H., Takaoka S., Uchida M., Ohashi M., et al. Regulation of Fas-mediated apoptosis in neutrophils after surgery-induced acute inflammation. J Surg Res 134 (2006) 114-123
26. Hagimoto N., Kuwano K., Kawasaki M., Yoshimi M., Kaneko Y., Kunitake R., et al. Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation. Am J Respir Cell Mol Biol 21 (1999) 436-445
27. Renshaw S.A., Parmar J.S., Singleton V., Rowe S.J., Dockrell D.H., Dower S.K., et al. Acceleration of human neutrophil apoptosis by TRAIL. J Immunol 170 (2003) 1027-1033
28. Marsik C., Halama T., Cardona F., Wlassits W., Mayr F., Pleiner J., et al. Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans. Shock 20 (2003) 493-496
29. Cassatella M.A. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils. J Leukoc Biol 79 (2006) 1140-1149
30. Kitamura Y., Hashimoto S., Mizuta N., Kobayashi A., Kooguchi K., Fujiwara I., et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med 163 (2001) 762-769
31. Kayagaki N., Kawasaki A., Ebata T., Ohmoto H., Ikeda S., Inoue S., et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182 (1995) 1777-1783
32. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263 (1994) 1759-1762
33. Hamann K.J., Dorscheid D.R., Ko F.D., Conforti A.E., Sperling A.I., Rabe K.F., et al. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. Am J Respir Cell Mol Biol 19 (1998) 537-542
34. Kuwano K., Kawasaki M., Maeyama T., Hagimoto N., Nakamura N., Shirakawa K., et al. Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia. Chest 118 (2000) 451-458
35. Baughman R.P., Gunther K.L., Rashkin M.C., Keeton D.A., and Pattishall E.N. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am J Respir Crit Care Med 154 (1996) 76-81
36. Meduri G.U., Kohler G., Headley S., Tolley E., Stentz F., and Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108 (1995) 1303-1314
37. Kwon B., Youn B.S., and Kwon B.S. Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes. Curr Opin Immunol 11 (1999) 340-345
38. Chaudhari B.R., Murphy R.F., and Agrawal D.K. Following the TRAIL to apoptosis. Immunol Res 35 (2006) 249-262